{"transactions":[{"id":749663,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":41363,"kind":"person","name":"Ferrara Napoleone","position":1,"cik":"0001744779","reported_name":"Ferrara Napoleone","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-04T20:36:07.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 3, 2026. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 3, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to continued service."}],"balance_after":9000,"derivative":{"exercise_price":4.72,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001193125-26-257556","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526257556/ownership.xml","form_type":"4"}},{"id":1173317,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":41363,"kind":"person","name":"Ferrara Napoleone","position":1,"cik":"0001744779","reported_name":"Ferrara Napoleone","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-11T21:03:27.000Z","date":"2025-04-10","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on April 10, 2025. The shares underlying the option are scheduled to vest over three years in equal monthly installments from March 18, 2025 through March 18, 2028, subject to continuous service."}],"balance_after":18000,"derivative":{"exercise_price":7.31,"expiration_date":"2035-04-09","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0000950170-25-053368","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017025053368/ownership.xml","form_type":"4"}},{"id":1200007,"issuer":{"id":6805,"kind":"organization","name":"Kalaris Therapeutics, Inc."},"owners":[{"id":41363,"kind":"person","name":"Ferrara Napoleone","position":1,"cik":"0001744779","reported_name":"Ferrara Napoleone","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-18T21:45:09.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":504000,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Shares issued upon closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 7, 2024 (the \"Merger Agreement\"), by and among the Issuer, Aurora Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Issuer, and Kalaris Tx, Inc. (previously named Kalaris Therapeutics, Inc.), a Delaware corporation (\"KTx\"), in exchange for outstanding shares of KTx pursuant to the terms and conditions of the Merger Agreement (such transaction, the Merger)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, as of the effective time of the Merger, each share of KTx common stock was converted into and became exchangeable for the right to receive 0.2016 shares of common stock of the Issuer."}],"balance_after":504000,"source":{"system":"sec-edgar","filing":"0000950170-25-041498","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754068/000095017025041498/ownership.xml","form_type":"4"}},{"id":3096739,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":41363,"kind":"person","name":"Ferrara Napoleone","position":1,"cik":"0001744779","reported_name":"Ferrara Napoleone","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2020-06-30T20:09:46.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":39567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 5, 2019, the reporting person received options to purchase 39,567 shares which were subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the 2020 Annual Meeting of Stockholders. Stockholder approval of the increase was obtained on June 26, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019."}],"balance_after":75000,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":39567},"source":{"system":"sec-edgar","filing":"0001213900-20-016306","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744779/000121390020016306/ownership.xml","form_type":"4"}},{"id":3419689,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":41363,"kind":"person","name":"Ferrara Napoleone","position":1,"cik":"0001744779","reported_name":"Ferrara Napoleone","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2019-09-09T20:52:00.000Z","date":"2019-09-05","kind":"grant","acquired":true,"shares":35433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019."}],"balance_after":35433,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":35433},"source":{"system":"sec-edgar","filing":"0000905718-19-000771","document":"delmarph_fm4sept52019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1744779/000090571819000771/delmarph_fm4sept52019.xml","form_type":"4"}},{"id":3419688,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":41363,"kind":"person","name":"Ferrara Napoleone","position":1,"cik":"0001744779","reported_name":"Ferrara Napoleone","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2019-09-09T20:52:00.000Z","date":"2019-09-05","kind":"grant","acquired":true,"shares":39567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the next annual meeting, the shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019."}],"balance_after":39567,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":39567},"source":{"system":"sec-edgar","filing":"0000905718-19-000771","document":"delmarph_fm4sept52019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744779/000090571819000771/delmarph_fm4sept52019.xml","form_type":"4"}},{"id":3544492,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":41363,"kind":"person","name":"Ferrara Napoleone","position":1,"cik":"0001744779","reported_name":"Ferrara Napoleone","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Stock Units","published_at":"2019-05-01T22:31:08.000Z","date":"2019-04-30","kind":"disposition_to_issuer","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents the right to receive one share of common stock, to vest upon achievement of specified targets related to the Company's financial performance. Such performance stock units were unvested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance stock unit represents the right to receive one share of common stock, to vest upon achievement of specified targets related to the Company's financial performance. Such performance stock units were unvested."}],"balance_after":0,"derivative":{"expiration_date":"2022-07-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-19-007625","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744779/000121390019007625/ownership.xml","form_type":"4"}},{"id":3767194,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":41363,"kind":"person","name":"Ferrara Napoleone","position":1,"cik":"0001744779","reported_name":"Ferrara Napoleone","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2018-11-13T21:40:31.000Z","date":"2018-11-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in twelve (12) equal monthly installments beginning on December 8, 2018."}],"balance_after":40000,"derivative":{"exercise_price":0.6099,"expiration_date":"2028-11-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-18-015519","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744779/000121390018015519/ownership.xml","form_type":"4"}},{"id":3883233,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":41363,"kind":"person","name":"Ferrara Napoleone","position":1,"cik":"0001744779","reported_name":"Ferrara Napoleone","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Stock Units","published_at":"2018-06-26T23:51:55.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents the right to receive one share of common stock upon vesting of the unit based on achievement of specified targets related to the Company's financial performance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance stock unit represents the right to receive one share of common stock upon vesting of the unit based on achievement of specified targets related to the Company's financial performance."}],"balance_after":200000,"derivative":{"expiration_date":"2022-07-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-18-008296","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1744779/000121390018008296/ownership.xml","form_type":"4"}},{"id":3883232,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":41363,"kind":"person","name":"Ferrara Napoleone","position":1,"cik":"0001744779","reported_name":"Ferrara Napoleone","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2018-06-26T23:51:55.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":54514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the award vests on May 31, 2019, the remainder of the award vests in equal installments each three months thereafter, commencing on August 31, 2019"}],"balance_after":54514,"derivative":{"exercise_price":0.7,"expiration_date":"2028-06-22","underlying":"Common Stock","underlying_shares":54514},"source":{"system":"sec-edgar","filing":"0001213900-18-008296","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744779/000121390018008296/ownership.xml","form_type":"4"}}]}